| 04/24/2026 3:15 PM | Canaan XI L.P. (1712417) Filed by Tyra Biosciences (1863127) Subject | Form SCHEDULE 13G/A | |
| 04/20/2026 3:30 PM | Dable Habib J (1690773) Reporting Tyra Biosciences (1863127) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 04/20/2026 3:31 PM | Dable Habib J (1690773) Reporting Tyra Biosciences (1863127) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/17/2026 7:08 AM | Tyra Biosciences (1863127) Filer | Form DEF 14A | |
| 04/17/2026 7:10 AM | Tyra Biosciences (1863127) Filer | Form DEFA14A | |
| 04/17/2026 7:11 AM | Tyra Biosciences (1863127) Filer | Form ARS | |
| 04/17/2026 7:02 AM | Tyra Biosciences (1863127) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/13/2026 3:44 PM | Bensen Daniel (1880946) Reporting Tyra Biosciences (1863127) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/07/2026 12:33 PM | FMR LLC (315066) Filed by Tyra Biosciences (1863127) Subject | Form SCHEDULE 13G | |
| 04/02/2026 3:38 PM | Rueb Yuliya (2125370) Reporting Tyra Biosciences (1863127) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 03/27/2026 3:44 PM | KAPLAN GILLA (1247024) Reporting Tyra Biosciences (1863127) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for TYRA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Tyra Biosciences and its competitors with MarketBeat's FREE daily newsletter.
|
| 03/25/2026 4:36 PM | KAPLAN GILLA (1247024) Reporting Tyra Biosciences (1863127) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/12/2026 4:42 PM | Bensen Daniel (1880946) Reporting Tyra Biosciences (1863127) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/06/2026 3:28 PM | RA CAPITAL MANAGEMENT, L.P. (1346824) Filed by Tyra Biosciences (1863127) Subject | Form SCHEDULE 13D/A | |
| 02/20/2026 7:14 AM | Farallon Capital Partners, L.P. (1175707) Filed by Tyra Biosciences (1863127) Subject | Form SCHEDULE 13G | |
| 02/13/2026 3:30 PM | Harris Todd (1711463) Filed by Tyra Biosciences (1863127) Subject | Form SCHEDULE 13G | |
| 02/13/2026 3:30 PM | Bensen Daniel (1880946) Reporting Tyra Biosciences (1863127) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/20/2026 3:30 PM | Bensen Daniel (1880946) Reporting Tyra Biosciences (1863127) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/12/2026 4:38 PM | Bensen Daniel (1880946) Reporting Tyra Biosciences (1863127) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/19/2025 8:00 PM | MORE ROBERT J (1207792) Reporting Tyra Biosciences (1863127) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/16/2025 3:30 PM | Bensen Daniel (1880946) Reporting Tyra Biosciences (1863127) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/01/2025 5:16 PM | Ashar Bhavesh (1849740) Reporting Tyra Biosciences (1863127) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 12/01/2025 5:17 PM | Ashar Bhavesh (1849740) Reporting Tyra Biosciences (1863127) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/01/2025 7:00 AM | Tyra Biosciences (1863127) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/25/2025 4:00 PM | MORE ROBERT J (1207792) Reporting Tyra Biosciences (1863127) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/21/2025 3:26 PM | Alta Partners NextGen Fund II, L.P. (1768658) Reporting Tyra Biosciences (1863127) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/19/2025 6:30 PM | Bensen Daniel (1880946) Reporting Tyra Biosciences (1863127) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/18/2025 4:04 PM | Bensen Daniel (1880946) Reporting Tyra Biosciences (1863127) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/17/2025 6:03 PM | Bensen Daniel (1880946) Reporting Tyra Biosciences (1863127) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/13/2025 4:40 PM | Bensen Daniel (1880946) Reporting Tyra Biosciences (1863127) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/17/2025 4:57 PM | Fuhrman Alan (1303521) Reporting Tyra Biosciences (1863127) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/21/2025 8:43 PM | Tyra Biosciences (1863127) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/14/2025 3:11 PM | Tyra Biosciences (1863127) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/14/2025 10:44 AM | JANUS HENDERSON GROUP PLC (1274173) Filed by Tyra Biosciences (1863127) Subject | Form SCHEDULE 13G/A | |
| 08/07/2025 3:43 PM | Fuhrman Alan (1303521) Reporting Tyra Biosciences (1863127) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/30/2025 7:07 AM | Tyra Biosciences (1863127) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/20/2025 4:42 PM | KAPLAN GILLA (1247024) Reporting Tyra Biosciences (1863127) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/16/2025 7:06 PM | Kolchinsky Peter (1384859) Reporting RA Capital Healthcare Fund LP (1315082) Reporting RA CAPITAL MANAGEMENT, L.P. (1346824) Reporting RA Capital Nexus Fund, L.P. (1780117) Reporting Shah Rajeev M. (1619841) Reporting Tyra Biosciences (1863127) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/16/2025 6:05 PM | KAPLAN GILLA (1247024) Reporting Tyra Biosciences (1863127) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/13/2025 3:22 PM | KAPLAN GILLA (1247024) Reporting Tyra Biosciences (1863127) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/11/2025 6:44 PM | Kolchinsky Peter (1384859) Reporting RA Capital Healthcare Fund LP (1315082) Reporting RA CAPITAL MANAGEMENT, L.P. (1346824) Reporting RA Capital Nexus Fund, L.P. (1780117) Reporting Shah Rajeev M. (1619841) Reporting Tyra Biosciences (1863127) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
|
| 06/06/2025 3:50 PM | RA CAPITAL MANAGEMENT, L.P. (1346824) Filed by Tyra Biosciences (1863127) Subject | Form SCHEDULE 13D/A | |
| 05/18/2025 11:15 PM | Tyra Biosciences (1863127) Filer | Form EFFECT | |
| 05/14/2025 10:47 AM | JANUS HENDERSON GROUP PLC (1274173) Filed by Tyra Biosciences (1863127) Subject | Form SCHEDULE 13G | |
| 05/12/2025 9:43 AM | FMR LLC (315066) Filed by Tyra Biosciences (1863127) Subject | Form SCHEDULE 13G/A | |
| 05/08/2025 3:30 PM | Tyra Biosciences (1863127) Filer | Form S-3 Registration statement under Securities Act of 1933 | |